Trials / Sponsors / iOx Therapeutics
iOx Therapeutics
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | IMM60 and Pembrolizumab in Melanoma and NSCLC Non-small Cell Lung Cancer, Melanoma | Phase 1 / Phase 2 | 2023-11-15 |
Trials / Sponsors / iOx Therapeutics
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | IMM60 and Pembrolizumab in Melanoma and NSCLC Non-small Cell Lung Cancer, Melanoma | Phase 1 / Phase 2 | 2023-11-15 |